รองศาสตราจารย์ ดร. โรจน์ฤทธิ์ โรจนธเนศ
- ห้อง 1405/3 อาคารมหามกุฎ ภาควิชาเคมี คณะวิทยาศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย แขวงวังใหม่ เขตปทุมวัน กทม. 10330
- 02-2187734
การศึกษา
- [2004] Ph.D., Chulalongkorn University
- [1998] B.B.A., Sukhothai Thammathirat University
- [1997] B.Sc. (2nd class honour), Chulalongkorn University
ประสบการณ์การทำงาน
- [2023 - present] Associate Professor, Chulalongkorn University
- [2008 - 2023] Assistant Professor, Chulalongkorn University
- [2005 - 2008] Lecturer, Chulalongkorn University
หัวข้องานวิจัยในปัจจุบัน
- Supramolecular chemistry on ionic nanoparticles and its biomedical applications
Research Themes
Ionic nanoparticles for drug delivery and control releasing applications
High-performance disinfectant
ทุนและรางวัล
- [2016] Scholarship from Ministry of university affairs
- [2001] Ministry of university affairs ScholarshipMassachusetts Lowell, USA
- [1999] Institute for promotion of teching science and technology Scholarship
- [1998] Tab Neelanithi Foudation Scholarship
ผลงานตีพิมพ์
•Synthesis and Structure-Property Relationship of meso-Substituted Porphyrin- and Benzoporphyrin-Thiophene Conjugates toward Electrochemical Reduction of Carbon Dioxide. Energy and Fuels.
2024. Cited 0
•Targeted Therapy with Cisplatin-Loaded Calcium Citrate Nanoparticles Conjugated with Epidermal Growth Factor for Lung Cancer Treatment. ACS Omega. 2024. Cited 0
•Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection. Biomedicine and Pharmacotherapy. 2023. Cited 5
•“Assessing exposure of printing factory workers in thailand to selected heavy metals using urine and hair as non-invasive matrices”. BMC Public Health. 2023. Cited 2
•Ca-EDTA restores the activity of ceftazidime-avibactam or aztreonam against carbapenemase-producing Klebsiella pneumoniae infections. iScience. 2023. Cited 10
Full list
•Targeted Therapy with Cisplatin-Loaded Calcium Citrate Nanoparticles Conjugated with Epidermal Growth Factor for Lung Cancer Treatment. ACS Omega. 2024. Cited 0
•Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection. Biomedicine and Pharmacotherapy. 2023. Cited 5
•“Assessing exposure of printing factory workers in thailand to selected heavy metals using urine and hair as non-invasive matrices”. BMC Public Health. 2023. Cited 2
•Ca-EDTA restores the activity of ceftazidime-avibactam or aztreonam against carbapenemase-producing Klebsiella pneumoniae infections. iScience. 2023. Cited 10
Full list